The ADEM trial
Monday 11 November: 11:00–12:30, Hall B1, Georgia World Congress Center, Atlanta, USA
Presenter: Christian Roux, Université Cote d'Azur, Nice, France
In this phase III trial, patients with symptomatic erosive hand osteoarthritis were given once weekly methotrexate 10 mg or placebo for 1 year. The primary endpoint is pain at 3 months, and secondary endpoints include clinical and radiographic features.